Cambridge, MA-based Helicos Biosciences (NASDAQ: [[ticker:HLCS]]), the maker of gene sequencing instruments, said today it has filed a lawsuit accusing Menlo Park, CA-based Pacific Biosciences of patent infringement. Helicos says it was the first to invent and market the technology known as single molecule sequencing, and that PacBio’s subsequent technology violates Helicos patents that extend to as far as 2028. PacBio, which is seeking to push the frontiers of faster/cheaper gene sequencing, filed paperwork last month for an attempt to raise $200 million through an IPO.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
